ro ru en

State
News
Agency

Republica Moldova 30 de ani de independență

Moldova to purchase over two million doses of anti-COVID-19 vacine through COVAX

18:33 | 16.04.2021 Category: Social

Chisinau, 16 April /MOLDPRES/ - The national committee on coordinating the immunization against Covid-19 today held a meeting and approved a quantity of 2,074,742 doses of vaccine, which are to be purchased through the cost-sharing mechanism of the COVAX platform.    

According to data by the Health, Labour and Social Protection Ministry, on 30 December 2020, Moldova submitted to COVAX an application, thereby requesting the covering of 50 per cent of the population with doses of vaccine against COVID-19, of which 20 per cent will be provided for free and 30 per cent – through the cost-sharing mechanism with preferential prices provided to Moldova.    

At the same time, a decision was taken to buy 100,000 doses of Corona Vac vaccine against COVID-19 through procedure of direct contracting.

Specialists reasoned the purchasing of a smaller quantity of Corona Vac vaccine, in the context of supplying the residents with vaccine at the level of 50 per cent through the COVAX platform, receiving more consignments of vaccine as donations, as well as continuous negotiation with vaccine producers.  

At the same time, the committee members considered the option to buy a quantity of Sputnik V vaccine, additionally to those 182,000 doses, which are to be received as donation. In the context, they ruled to ask for a commercial bid of the producer of Sputnik V vaccine from the Russian Direct Investment Fund, for 700,000 doses of Sputnik V vaccine.   

Under the National Plan on anti-COVID-19 Immunization, Moldova is set to vaccinate about 70 per cent of the residents against the new-type coronavirus.  

Symbol photo

 

Any material published on the website of the Public Institution ’’A.I.S. Moldpres’’ (Moldpres News Agency) is intellectual peoperty of the Agency, protected by the copyright. The taking over or/and use of these materials will be made only with the Agency’s agreement and with compulsory reference to source.